Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department von Carpio, Ricardo, Zapata, Juan, Spanuth, Eberhard, Hess, Georg

Volltext

Checkpoint Inhibition in Non-Hodgkin's Lymphoma von Heß, Georg

Volltext

Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis von Rule, Simon, Dreyling, Martin, Goy, Andre, Hess, Georg, Auer, Rebecca, Kahl, Brad, Hernández-Rivas, José-Ángel, Qi, Keqin, Deshpande, Sanjay, Parisi, Lori, Wang, Michael

Volltext

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study von Dreyling, Martin, Prof Dr, Jurczak, Wojciech, MD, Jerkeman, Mats, MD, Silva, Rodrigo Santucci, MD, Rusconi, Chiara, MD, Trneny, Marek, Prof, Offner, Fritz, MD, Caballero, Dolores, MD, Joao, Cristina, Prof, Witzens-Harig, Mathias, Prof, Hess, Georg, MD, Bence-Bruckler, Isabelle, MD, Cho, Seok-Goo, Prof, Bothos, John, PhD, Goldberg, Jenna D, MD, Enny, Christopher, BS, Traina, Shana, PhD, Balasubramanian, Sriram, PhD, Bandyopadhyay, Nibedita, PhD, Sun, Steven, PhD, Vermeulen, Jessica, MD, Rizo, Aleksandra, MD, Rule, Simon, Prof

Volltext

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma von HESS, Georg, HERBRECHT, Raoul, HANUSHEVSKY, Orysia, CLANCY, Jill, HEWES, Becker, MOORE, Laurence, COIFFIER, Bertrand, ROMAGUERA, Jorge, VERHOEF, Gregor, CRUMP, Michael, GISSELBRECHT, Christian, LAURELL, Anna, OFFNER, Fritz, STRAHS, Andrew, BERKENBLIT, Anna

Volltext

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the Internat... von Ferreri, Andrés J M, Dr, Cwynarski, Kate, MD, Pulczynski, Elisa, MD, Ponzoni, Maurilio, Prof, Deckert, Martina, Prof, Politi, Letterio S, MD, Torri, Valter, MD, Fox, Christopher P, MD, Rosée, Paul La, MD, Schorb, Elisabeth, MD, Ambrosetti, Achille, Prof, Roth, Alexander, MD, Hemmaway, Claire, MD, Ferrari, Angela, MD, Linton, Kim M, PhD, Rudà, Roberta, MD, Binder, Mascha, Prof, Pukrop, Tobias, Prof, Balzarotti, Monica, MD, Fabbri, Alberto, MD, Johnson, Peter, Prof, Gørløv, Jette Sønderskov, PhD, Hess, Georg, MD, Panse, Jens, MD, Pisani, Francesco, MD, Tucci, Alessandra, MD, Stilgenbauer, Stephan, Prof, Hertenstein, Bernd, MD, Keller, Ulrich, Prof, Krause, Stefan W, Prof, Levis, Alessandro, MD, Schmoll, Hans J, MD, Cavalli, Franco, Prof, Finke, Jürgen, Prof, Reni, Michele, MD, Zucca, Emanuele, MD, Illerhaus, Gerald, Prof

Volltext

Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evalua... von FAYAD, Luis, OFFNER, Fritz, COIFFIER, Bertrand, CZUCZMAN, Myron, GINE, Eva, DURRANT, Simon, KNEISSL, Michelle, LUU, Kenneth T, HUA, Steven Y, BONI, Joseph, VANDENDRIES, Erik, DANG, Nam H, SMITH, Mitchell R, VERHOEF, Gregor, JOHNSON, Peter, KAUFMAN, Jonathan L, ROHATINER, Ama, ADVANI, Anjali, FORAN, James, HESS, Georg

Volltext

Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses von Alflen, Astrid, Stadler, Nicole, Aranda Lopez, Pamela, Teschner, Daniel, Theobald, Matthias, Heß, Georg, Radsak, Markus P.

Volltext

The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation von Stadler, Nicole, Hasibeder, Astrid, Lopez, Pamela Aranda, Teschner, Daniel, Desuki, Alexander, Kriege, Oliver, Weber, Alexander N R, Schulz, Christoph, Michel, Christian, Heβ, Georg, Radsak, Markus P

Volltext

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease von Krawczyk, Marcin, Zimmermann, Simone, Hess, Georg, Holz, Robert, Dauer, Marc, Raedle, Jochen, Lammert, Frank, Grünhage, Frank

Volltext

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas von Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva, Acker, Fabian, Fuhrmann, Stephan, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caillé, Léandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter, Dietrich, Sascha

Volltext

What is the best time for psychosocial counselling from the perspective of cancer patients and their relatives? A multi‐centre qualitative study von Singer, Susanne, Kojima, Erika, Deppisch, Larissa, Taylor, Katherine, Wickert, Martin, Riedel, Petra, Alt, Jürgen, Heß, Georg, Hechtner, Marlene, Bayer, Oliver

Volltext

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study von Morschhauser, Franck, Bouabdallah, Kamal, Stilgenbauer, Stephan, Thieblemont, Catherine, de Guibert, Sophie, Zettl, Florian, Gelbert, Lawrence M, Turner, Kellie P, Prasad Kambhampati, Siva Rama, Li, Li, Li, Lily Q, Buchanan, Sean, Barriga, Susana, Bear, Melissa M, Wilhelm, Martin, Hess, Georg

Volltext

Temsirolimus for the treatment of mantle cell lymphoma von Hess, Georg

Volltext

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation von Schorb, Elisabeth, Kasenda, Benjamin, Atta, Johannes, Kaun, Stephan, Morgner, Anke, Hess, Georg, Elter, Thomas, von Bubnoff, Nikolas, Dreyling, Martin, Ringhoffer, Mark, Krause, Stefan W, Derigs, Günter, Klimm, Beate, Niemann, D, Fritsch, Kristina, Finke, Jürgen, Illerhaus, Gerald

Volltext

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies von Topp, Max, Dlugosz-Danecka, Monika, Skotnicki, Aleksander B, Salogub, Galina, Viardot, Andreas, Klein, Andreas K, Hess, Georg, Michel, Christian S, Grosicki, Sebastian, Gural, Alex, Schwarz, Sylvia E, Pietzko, Kerstin, Gärtner, Ulrike, Strassz, András, Alland, Leila, Mayer, Jiri

Volltext

Long‐term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow‐up von Dreyling, Martin, Goy, Andre, Hess, Georg, Kahl, Brad S., Hernández‐Rivas, José‐Ángel, Schuier, Natasha, Qi, Keqin, Deshpande, Sanjay, Zhu, Angeline, Parisi, Lori, Wang, Michael L.

Volltext

Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis von Stolz, Claudia, Hess, Georg, Hähnel, Patricia S., Grabellus, Florian, Hoffarth, Sandra, Schmid, Kurt W., Schuler, Martin

Volltext

Transplantation in follicular lymphoma: not "yes or no" but "whom and when" von Hess, Georg, Meyer, Ralf Georg

Volltext

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease von Krawczyk, Marcin, Zimmermann, Simone, Hess, Georg, Holz, Robert, Dauer, Marc, Raedle, Jochen, Lammert, Frank, Grünhage, Frank

Volltext